Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Alex Therapeutics Raises €3.5M in Oversubscribed Financing round from Top Tier VC Investors to Advance Expansion in Europe and the US.
Stockholm-based Digital Therapeutics (DTx) company Alex Therapeutics today announces it has secured a €3.5M funding round, led […]
European Healthtech Mindgram Closes €7 Million Seed Round and Begins Its European Expansion
Mindgram, the European B2B platform providing integrated support for employees in the well-being sphere, has […]
CardioRenal Raises €3.3 million
CardioRenal, a company specialized in improving treatment at home for patients with severe chronic kidney […]
Radiaction Medical Ltd. Receives FDA Clearance for its Innovative Radiation Protection System and Secures $10M for US Launch and Commercialization
Radiaction Medical Ltd. (“Radiaction”), an innovative medical device company focused on radiation protection in the interventional […]
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined […]
XNK Therapeutics Raises SEK 132 Million to Accelerate Growth
XNK Therapeutics AB (“XNK”) today announced it has secured a private placement of SEK 132 million, […]
Osso VR Raises $66 Million to Broaden Access to Surgical Education for Healthcare Professionals
Osso VR, a validated virtual reality (VR) surgical training and assessment platform, today announced that […]
NHS Announces £127m Maternity Boost for Patients and Families
The NHS in England has today announced a £127 million funding boost for maternity services across […]
Geneos Therapeutics Secures $17 Million in Series A2 Financing to Advance Personalized Cancer Immunotherapy Platform
Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of tumor neoantigen targeted […]
KeyZell Start-up Plans to Reach 5 Million Euros in Private Investment and Become the New Biotech Unicorn
KeyZell, a Spanish biotechnology company in the development phase of digital cancer treatments and tools, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more